The titles of the pharmaceutical company Shire Pharmaceuticals back from recent lows after the public offer of exchange against the Canadian company BioChem. Shire rises of 6.7% at 11.10 pounds, rebounded from the lows of the last 10 months. Under the terms of the offer, the exchange ratio ranges between 47.2 and 70.8 U.S. dollars, according to the assessment of the subsidiary of American Depositary, listed on the Nasdaq.

Related posts

• Incepta buy public relations in the U.S. (0)
• Stockholm: Framfab plummeting by 35% (0)
• RWE offers 7.6 billion dollars for Water Works (U.S.) (0)
• Postponed the “porn” on the Neuer Markt (0)
• AstraZeneca (UK) disappoints the market (0)